1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Caplacizumab
Trade Name:
Cablivi
Manufacturer/Distributor:
sanofi-aventis Canada Inc.
Classification:
Antithrombotic agent
ATC Class:
B01AX07 - antithrombotic agent
Status:
active
Notice of Compliance (yyyy/mm/dd):
2020/02/28
Date Marketed in Canada (yyyy/mm/dd):
2020/09/04
Presentation:
Powder for solution 11 mg. DIN: 02496194
Comments:
For the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange (PE) and immunosuppressive therapy.
Back to:
Drug Product Listings 
